Sandbox Reserved 1761

This Sandbox is Reserved from November 4, 2022 through January 1, 2023 for use in the course CHEM 351 Biochemistry taught by Bonnie Hall at the Grand View University, Des Moines, USA. This reservation includes Sandbox Reserved 1755 through Sandbox Reserved 1764.

To get started: Click the edit this page tab at the top. Click on Show preview and then Save the page after each step, then edit it again. show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page. Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc. More help: Help:Editing

Human ornithine aminotransferase (hOAT)

spinqualitylabelsall models Caption for this structure Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image   Print3D This is a default text for your page '. Click above on edit this page' to modify. Be careful with the < and > signs. You may include any references to papers as in: the use of JSmol in Proteopedia or to the article describing Jmol to the rescue. GABA Function of your protein The specific function of Human ornithine aminotransferase (hOAT) is that of an enzyme. It can be found in humans, as well as mice and pigs. It helps transfer L-ornithine’s δ-amino group to α-ketoglutarate (α-KG). There is a lack of understanding in regards to hOAT's catalytic mechanism, even though it is a key component of human metabolism. As noted in the article, hOAT operates on a "Bi-Bi, Ping-Pong" kinetic mechanism resulting in the first part of the reaction undergoing a conversion of PLP -> PMP and L-Orn -> L-GSA. Then PMP's amino group is catalyzed by hOAT creating an α-KG. DABA The binding affinities of GABA and AVA were higher and resulted in slower turnovers. This raised the question that AVA and GABA would be good drug targets, rather than specifically hOAT. Biological relevance and broader implications hOAT is important because it is heavily involved in the urea cycle. In mammals, it dictates a large portion of the development of neonates. The research on this protein is relevant to science as a whole because it could directly impact cancer research and lead to the creation of cancer management in humans. There has been overexpression of hOAT within Hepatocellular carcinoma (HCC) cells, therefore there is reason to believe that the overexpression of hOAT is an indication of chronic liver diseases and cancer of the liver. The inhibitors include: y-aminobutyric acid (GABA), 5-aminovaleric acid (AVA), and L-2,4-diaminobutyric acid (DABA). The highest affinity of binding with hOAT is GABA. It also has a higher percentage of return in the reverse reaction. The more that hOAT is understood and researched, the more inactivators can be designed to combat the overexpression of hOAT that is found in conjunction to HCC. Important amino acids The ligand of hOAT is Pyridoxal-5'-Phosphate (PLP). The role of the catalytic amino acids in an enzyme is to bind to a substrate, changing the structure, causing bonds to break and new bonds to be formed. When there is a difficult reaction, the triad of amino acids works in tandem to facilitate the reaction. A Glu 235-Arg 413 salt bridge was found on AVA, but not on GABA. In regards to GABA, the salt bridge was disrupted in 30% of the monomers. The crystal soaking experiments created an opportunity to decipher the reaction intermediates of the structures. While GABA linked to PLP covalently, PLP and catalytic Lys 292 were linked by AVA. Structural highlights Main Secondary Features Tertiary/Quaternary Features Space filling view of PLP Space filling view of ''h''OAT is relevant because it shows the space that the atoms of the structure take up. 5-aminovaleric acid (AVA) lacking α-amino group does not impact the initial binding of the substrate and enzyme.

References

Butrin, A., Butrin, A., Wawrzak, Z., Moran, G. R., & Liu, D. (2022). Determination of the ph dependence, substrate specificity, and turnovers of alternative substrates for human ornithine aminotransferase. Journal of Biological Chemistry, 298(6), 101969. https://doi.org/10.1016/j.jbc.2022.101969